Clinical Trial

RADIANCE Continued Access Protocol

Study acronym: RADIANCE CAP
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to allow for the on-going collection of safety and effectiveness data in subjects with uncontrolled hypertension despite the prescription of antihypertensive medications.
Protocol Amendment History 27 amendments
This ClinicalTrials.gov record has been amended 27 times since 2021-08-17; most recent amendment 2024-06-13.
Status change: Recruiting → Active, Not Recruiting 2023-11-08
Status change: Not Yet Recruiting → Recruiting 2022-05-05
Trial Details
NCT Number NCT05017935
Lead Sponsor ReCor Medical, Inc.
Conditions Hypertension, Hypertension, Resistant to Conventional Therapy, Vascular Diseases, Cardiovascular Diseases
Enrollment 300 participants
Start Date 2022-05-04
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-06-17